chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient was hospitalized due to breakthrough infection. Patient appears to have received three doses of both the Pfizer and Moderna vaccine per chart review in the EMR. Patient was hospitalized from 01/30/22 - 02/02/22. Below is copied from discharge summary:   Patient is a 74 y.o. female patient who is being discharged today.   Hospital Course:    Acute on chronic respiratory failure due to COVID-19 pneumonia  Hypercoagulable state due to above History of COPD/lung cancer remission D-dimer 2046, patient has a history of hemorrhagic pancreatitis while on Eliquis, will avoid anticoagulation at this time, unable to do CTA due to renal function NM perfusion scan indeterminate, scattered areas of decreased perfusion present, likely related to pulm emphysema  Dexamethasone 6 milligram X 10 days  Albuterol q.4 hours Symbicort b.i.d. Robitussin p.r.n.  Nasal cannula 3 liters    AKI on chronic kidney disease  Cr improving 25/1.41  Bicarb 20  BMP daily a.m.    Hyponatremia 139    Hypothyroidism Levothyroxine 125 micrograms daily    Arterial hypertension  Toprol 12.5 milligram p.o. daily    History of PE NM perfusion scan indeterminate, scattered areas of decreased perfusion present, likely related to pulm emphysema    Leukopenia - Resolved    Patient is discharged in stable condition with stable vital signs. All questions rearding hospital course and plan of care after discharge have been answered to satisfaction. Prescriptions for medications needed to be taken after discharge have been given to patient. Patient has been instructed to follow up with PCP, MD within the next 7 days after discharge. Patient verbalizes understanding all given instructions and has no further doubts regarding discharge.
Received vaccination 5/9/12. Developed maculopapular rash immediately after vaccination spreading from face to rest of his body. Also has been very irritable and itchy for 2 days: 26 hours after shot he had crying all night.
Patient stated right leg started to begin tingling around 11:30 am on the 5/23/2023 and she called this nurse around 1:20 saying her right leg was feeling numb from thigh to knee. No other symptoms. When I told her we would get her into see provider she asked if she was having an allergic reaction. I informed her I was not a provider and could not tell her that. She would have to see the provider. She then said, well if it is not an allergic reaction, I really do not want to see a provider. I explained to her I could not say, and she should see the provider. She verbalized understanding of instructions given. Appointment made to see provider at clinic at 2:20.
itching; Rapid heartbeat; sweats; very tiredness; hot flashes; This non-serious case was reported by a consumer and described the occurrence of pruritus in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced pruritus (Verbatim: itching), heartbeats increased (Verbatim: Rapid heartbeat), sweating (Verbatim: sweats), tiredness (Verbatim: very tiredness) and hot flashes (Verbatim: hot flashes). The outcome of the pruritus, heartbeats increased, sweating, tiredness and hot flashes were not reported.   It was unknown if the reporter considered the pruritus, heartbeats increased, sweating, tiredness and hot flashes to be related to Shingrix.     It was unknown if the company considered the pruritus, heartbeats increased, sweating, tiredness and hot flashes to be related to Shingrix.   Additional Information: Receipt date: 06-AUG-2023 The patient reported that he/she had bad effects from the Shingrix shots. Rapid heartbeat, sweats, very tiredness, itching, hot flashes.
Minor itchiness and a small raised (approximately 0.5 inch diameter) bump at the vaccination site on my left arm.
Body chills, fever of 101.2, malaise/fatigue, cough, shortness of breath, diarrhea, nausea, headaches, myalgias.
Hib injection was given first, followed by Prevnar. After the Prevnar was given pt began holding his breath with his mouth open in a crying position. This continued to the point where he should have been crying. I picked him up and patted him on the back. He started crying audibly. I positioned him to see his face. His eyes became glazed appearing and remained open. He appeared to lose consciousness with his eyes open. His arms remained out to the side with his elbows flexed. He did not feel limp and he did not have any muscle movements. The whole episode lasted approx 1 min 1 1/4 min with the unconscious episode approx 10-15 seconds. Vital signs were monitored over the next two hours and were stable Tylenol was given orally to prevent fever. During this time he slept and was awake taking his bottle. His mother was given instructions for follow up. He returned the following morning. He remained afebrile without further Tylenol. He had eaten, slept normally and acted normally without further problems.
I went to the lab and obtained the influenza vaccine, placed the needle on the syringe and expressed the gas. I administered the Pfizer vaccine without complications.  I then mistook a Moderna bivalent booster for the iinfluenza vaccine and admnistered it in the opposite arm.  I recognized the influenza vaccine and told the patient about my mistake.  I reported the event to clinic chief.  Jointly, she, I and the patient decided to give the influenza vaccine, again without complications.  I observed the patient for fifteen minutes.  She reported no untoward effects, and returned to work, where she was to be close to a number of people.  The day after the event, the patient reported she was all right.
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 71-year-old male patient received BNT162b2 (BNT162B2), on 22Dec2020 as dose 1, single (Lot number: EL0140), in left arm, on 12Jan2021 as dose 2, single (Lot number: EL3302), in left arm, on 05Oct2021 at 15:00 as dose 3 (booster), single (Lot number: EW0183), in left arm and on 29Mar2022 at 16:00 as dose 4 (booster), single (Lot number: FK9729) at the age of 71 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "asthma" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Jun2022, outcome "unknown" and all described as "COVID-19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jun2022) positive, notes: I tested positive for COVID-19; (Jun2022) Negative, notes: I tested negative 3 days after completion of 5 day Paxlovid course. Therapeutic measures were taken as a result of vaccination failure, covid-19.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: The reported Covid 19 positive after both the doses of  COVID-19 immunization is considered ineffective of BNT162B2, and the Company cannot completely exclude the possible causality between the reported events and BNT162B2 administration.
This report describes the occurrence of mercury poisoning in a female child of unspecified age who was vaccinated with hep B vaccine recombinant (Engerix B) for prophylaxis. This report was received as part of litigation proceedings and has not been verified by a physician or other healthcare professional. The subject's medical history, concurrent conditions, and concurrent medications were not reported. The subject received injections of Engerix B on 1/4/95 (lot 1513B2)( and 2/8/96 (lot 1950A2). She also received injections of Tetramune 2/8/96 and Tri-Immunol 4/22/96. The subject's attorney alleged that "As a result of the mercury in the Thimerosal-containing vaccinations that the subject received she now suffers, and in the future will continue to suffer, from the toxic neurological effects of mercury poisoning." The attorney further alleged that the subject "has developed severe neurodevelopmental disroders with associated high mercury exposure levels as a result of the vaccinations she received, and has suffered serious permanent injury." Onset and treatment of the events were not specified. The mercury poisoning in this report, with resultant neurodevelopmental disorders, is considered medically serious (OMIC).
Symptoms within a few minutes of vaccine administration: body aches and headaches (although these two specifically are not uncommon for pt), jaw pain, left arm shaking until bedtime that night, twitching (also not uncommon for pt per seizure disorder). Symptoms resolved by next morning at 7am, but within 2 hours, symptoms returned, including swollen face that is painful to the touch, intense fatigue, burning/throbbing/tingling sensation in arms and legs, worsening of arthritic pain, jaw pain, chills/hot flash-like episodes, decreased appetite, stinging sensation in the eye, home measurement had pulse ox 98% and HR at 93 bpm (pt endorsed). Note that pt was COVID positive on Dec 1st, 2020
Myalgia left arm pain, redness, induration and fever up to to 104 F, Narrative:   On the evening of 12/29/2020, she started noting 3 cm L arm pain swelling, redness, induration and warmth to L arm at site of vaccination. On 12/30 - she had chills, body aches, felt clammy and had temp of 104 F. She took Tylenol. On 12/31 her temp was 102 F at 5 am and 101.7 F at 12:30 pm. Took Tylenol. Her L arm swelling redness and warmth has decreased in size and pain also decreased. She had some SOB associated with fever spikes.
A report was received from a regulatory authority on 12/6/02 concerning a 74 year old female vaccinee who experienced thrombocytopenic purpura which lead to hospitalization, 21 days after receiving the Fluvirine vaccine on 10/9/02.  The vaccinee had a history of hypertension, hypertrophic cardiomyopathy, hypercholesterolemia and asthma. The vaccinee was receiving spironelactose, verapamil, formeterol fumerate, pravastatin, beclometasone and naftidrofuryl oxalate concomitantly. During October 2002, the vaccinee took arthrotec 2 or 3 times for arthritic knee pain and on 10/16/02, fluoxetine was commenced for depression. On 10/30/02, the vaccinee experienced general purpuric lesions on all 4 limbs, complicated with oral hemorrhagic lesions and epistaxis. The vaccinee was hospitalized on 11/1/02. The vaccinee had a platelet count of 2000/mm^3 which led to the diagnosis of thrombocytopenic purpura. All drugs were discontinued. Treatment with IV corticotherapy and normal human immunoglobulins was given for 5 days. Platelets were transfused. A myelogram seemed to show a peripheric thrombocytopenia (rich spina; no malignant cells; normal and heavy megakaryocytes). On 11/6/02, the IV corticotherapy was replaced by prednisone. The purpura decreased and the platelet count increased (64,000/mm^3 on 11/6/02; 212,000 mm^3 on 11/7/02. On 11/8/02 verapamil and formoterol fumarate were restarted. On 11/15/02 the platelets were 616,000/mm^3. The anti-nuclear antibody, HIV, Hepatitis B and C tests were all negative and the direct Coomb's tests was positive. The vaccinee had a positive serology for Parvovirus B19. The vaccinee was considered to have recovered on 11/15/02. The reporter has assessed the relationship of the vaccine to the event as possible.
Chills; sick; Fever; hard for me to walk; Atrial fibrillation; blood clot in her finger; thumb right now is real cold; the tip of my thumb is numb; tip was numb and real cold- there was no circulation going on; Irregular heartbeat; Blood pressure high; Headache; Muscle ache; This is a spontaneous report from a contactable consumer, the patient, via the Pfizer-sponsored program. A female patient of an unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot: Unknown), via an unspecified route of administration on 19Apr2021 as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient previously received the first dose BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) on 19Mar2021 for COVID-19 immunization and felt fine (no adverse event). On an unspecified date in Apr2021, four days after the second vaccination, the patient was sick for seven days with chills. On an unspecified date in 2021, the patient had terrible side effects such as muscle ache and fever ("99 something") for 7 days. On an unspecified date in 2021, the patient experienced headache, blood pressure high, irregular heartbeat, atrial fibrillation and the calf was "real bad"- it was hard for the patient to walk. The patient called her doctor and got tested for COVID-19 two weeks after the vaccination, in May2021, with negative results. The doctor stated that the patient got so sick from the shot. On an unspecified date in 2021, the patient's thumb was like a blood clot to the thumb (blood clot in her finger), the tip was numb and real cold- there was no circulation going on. The patient went to the emergency room where an ultrasound was performed on the arm to see if there were any blood clots in there, with unknown results. The patient was treated with an unspecified "pill" for irregular heartbeat. The patient was scheduled for an echocardiogram and heart monitor. The clinical outcome of atrial fibrillation, blood clot in her finger, thumb right now is real cold, the tip of my thumb is numb, "tip was numb and real cold- there was no circulation going on", irregular heartbeat, blood pressure high, headache, muscle ache, chills, sick, fever, "hard for me to walk" was unknown.  Information on the lot/batch number has been requested
Could barely move arm in the morning; Felt like she was about to pass out; Felt dizzy; Felt weak/had no energy; Area is real hot; Swelling at injection site/swollen/Knot at injection site; Pain at injection site; Rash forming at injection site; Headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (Could barely move arm in the morning), FEELING ABNORMAL (Felt like she was about to pass out), DIZZINESS (Felt dizzy), ASTHENIA (Felt weak/had no energy) and VACCINATION SITE WARMTH (Area is real hot) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Breast cancer (in 2010 for which she was on chemotherapy and radiation). Concomitant products included MONTELUKAST SODIUM (SINGULAIR) for an unknown indication.    On 16-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (Could barely move arm in the morning), FEELING ABNORMAL (Felt like she was about to pass out), DIZZINESS (Felt dizzy), ASTHENIA (Felt weak/had no energy), VACCINATION SITE WARMTH (Area is real hot), VACCINATION SITE SWELLING (Swelling at injection site/swollen/Knot at injection site), VACCINATION SITE PAIN (Pain at injection site), VACCINATION SITE RASH (Rash forming at injection site) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (Could barely move arm in the morning), FEELING ABNORMAL (Felt like she was about to pass out), DIZZINESS (Felt dizzy), ASTHENIA (Felt weak/had no energy), VACCINATION SITE WARMTH (Area is real hot), VACCINATION SITE SWELLING (Swelling at injection site/swollen/Knot at injection site), VACCINATION SITE PAIN (Pain at injection site), VACCINATION SITE RASH (Rash forming at injection site) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient was on tramadol and flexeril, but hasn't taken tramadol and flexeril in a while.
5 CM X 3 CM ERYTHMATOUS LESION ON THE SITE OF INJECTION ON THE LEFT ARM. WARM AND TENDER TO TOUCH.
Left leg upper thigh hot, redness, swollen and hard. Pt went to ER diagnosis cellulitis.
This spontaneous report as received from a nurse refers to a 16 year old male patient. Medical history and concurrent conditions were none. Illness at the time of vaccination was none. On 24-AUG-2015 at 10:10 am, the patient was vaccinated with a third dose of improperly stored GARDASIL (lot # K011562, expiry date: 08-APR-2017) intramuscular in the left arm. No adverse event was reported. No concomitant therapy was reported. This is one of the six reports received from the same reporter. Additional information is not expected as all correspondence was received.
Information has been received from a physician concerning a male who was vaccinated PO with the first and second 2mL doses of Rotateq. Subsequently, after each dose, the patient was constipated for about 3 days. At the time of the report, the patient was "about 6-months-old and received his third dose but the physician did not know if the adverse experience repeated". No medical attention was sought. There were no lab diagnostic studies performed. There was no product quality complaint. Additional information has been requested. This is one of several reports received from the same source.
G45.9 TRANSIENT CEREBRAL ISCHEMIA 3/25/2023 HTN (HYPERTENSION) G47.33 ADULT OBSTRUCTIVE SLEEP APNEA 4/17/2023 HTN (HYPERTENSION)
Pfizer covis vaccine was mixed with 0.8 ml of saline instead of 1.8ml
Pt has immunizations on 6/14/07, 6/23/07 while on vacation she had a fever, seizure activity and later a rash. Was taken to hospital for treatment. I need to file a VAER's report and need your information from this hospital visit. records received with report-DX febrile seizure right upper lobe pneumonia.
This case was reported by a consumer via other manufacturer and described the occurrence of feeling unwell in a adult patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, 1 day after receiving SHINGRIX, the patient experienced feeling unwell. On an unknown date, the outcome of the feeling unwell was unknown. It was unknown if the reporter considered the feeling unwell to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The age group was not reported but was selected as adult as per vaccine indication. The primary reporter was the caller who said that she heard from a physician that the patient who get SHINGRIX did not feel well the next day of vaccination. No further adverse event information was provided.
headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).   On 09-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 10-Feb-2021, the patient experienced HEADACHE (headache). At the time of the report, HEADACHE (headache) outcome was unknown.             No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-031245 (Patient Link).
Hives on all over body; Maternal exposure during pregnancy; This spontaneous retrospective pregnancy case was reported by a consumer and describes the occurrence of URTICARIA (Hives on all over body) and MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced URTICARIA (Hives on all over body) and MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy). The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. At the time of the report, URTICARIA (Hives on all over body) outcome was unknown and MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concamitant medication was reported by the reporter. No treatment medication was reported. Age of the patient was reported as 34 or 35 years and patient was going through post partum.
This spontaneous report as received from a now 67 year old female patient refers to herself. On an unknown date, the patient was vaccinated with a dose of PCV (manufacturer unknown) (lot#, expiry date, route, dose and strength not reported). On an unknown date, the patient experienced infection and severe swelling of arm. The outcome of the events was unknown. It was unspecified if the patient sought medical attention. The patient experienced severe skin rash while taking OXYTROL (for women) (OTC product) which was captured in case MARRS#1312USA009541. Additional information has been requested.
9:00 shot administered. 9:20 joints started aching. Aching kept getting worse and eventually I became nauseous. 11:20 threw up, heart started racing. Checked in with nurses that gave shot. They recommended 2 ADVIL, water/Gatorade, rest and to call my doctor. 11:30 took 2 ADVIL and laid down. Was very cold. Tried to control my breathing and slow down my heart rate. 12:05 Headed home. Aching in joints was extreme. It was painful to walk or grasp things, was very cold, and had a hard time controlling breathing. Drank Gatorade and water. 1:00 went to sleep under lots of blankets. 3:15 woke up, was very warm (slight fever), heart racing had stopped. Drank more Gatorade. 4:00 only aching joints but kept pretty much under control with more ADVIL. Felt exhausted. Next Day 9/12 aching joints but felt better with ADVIL. Very tired. 9/13 achiness almost gone, still tired.